EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aberrant neurodevelopment in human iPS cell‐derived models of Alexander disease

Zuzana Matusova iD, Werner Dykstra iD, Yolanda de Pablo iD, Oskar G Zetterdahl iD, Isaac Canals iD, Charlotte A G H van Gelder iD, Harmjan R Vos iD, Dolores Pérez-Sala iD, Mikael Kubista iD, Pavel Abaffy iD, Henrik Ahlenius iD, Lukas Valihrach iD und 2 weitere

Glia · 2025

DOI: 10.1002/glia.24618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, 2025. Verfasst von Zuzana Matusova und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Gene Expression, Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czechia. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Alexander Disease, Glial Fibrillary Acidic Protein, Astrocytes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EJP RD - European Joint Programme on Rare Diseases, Swedish Research Council, 'la Caixa' Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alexander disease (AxD) is a rare and severe neurodegenerative disorder caused by mutations in glial fibrillary acidic protein (GFAP). While the exact disease mechanism remains unknown, previous studies suggest that mutant GFAP influences many cellular processes, including cytoskeleton stability, mechanosensing, metabolism, and proteasome function. While most studies have primarily focused on GFAP‐expressing astrocytes, GFAP is also expressed by radial glia and neural progenitor cells, prompting questions about the impact of GFAP mutations on central nervous system (CNS) development. In this study, we observed impaired differentiation of astrocytes and neurons in co‐cultures of astrocytes and neurons, as well as in neural organoids, both generated from AxD patient‐derived induced pluripotent stem (iPS) cells with a GFAP R239C mutation. Leveraging single‐cell RNA sequencing (scRNA‐seq), we identified distinct cell populations and transcriptomic differences between the mutant GFAP cultures and a corrected isogenic control. These findings were supported by results obtained with immunocytochemistry and proteomics. In co‐cultures, the GFAP R239C mutation resulted in an increased abundance of immature cells, while in unguided neural organoids and cortical organoids, we observed altered lineage commitment and reduced abundance of astrocytes. Gene expression analysis revealed increased stress susceptibility, cytoskeletal abnormalities, and altered extracellular matrix and cell–cell communication patterns in the AxD cultures, which also exhibited higher cell death after stress. Overall, our results point to altered cell differentiation in AxD patient‐derived iPS‐cell models, opening new avenues for AxD research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsAlexander DiseaseGlial Fibrillary Acidic ProteinAstrocytesCell DifferentiationHumansNeuronsCoculture TechniquesMutationOrganoidsCells, CulturedNeural Stem Cells

Stichwörter der Autor:innen

Alexander diseaseGFAPiPS cellsneural organoids

Substanzen

Glial Fibrillary Acidic ProteinGFAP protein, human

Autor:innen und Institutionen

  • Laboratory of Gene Expression, Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czechia.
  • Faculty of Science, Charles University, Prague, Czechia.
  • Department of Translational Neuroscience, University Medical Centre Utrecht Brain Centre, Utrecht University, Utrecht, The Netherlands.
  • Laboratory of Astrocyte Biology and CNS Regeneration, Center for Brain Repair, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenbu…
  • Stem Cells, Aging and Neurodegeneration Lab, Department of Experimental Medical Science, Faculty of Medicine, Lund Stem Cell Center, Lund University, Lund, Sweden.
  • Glial and Neuronal Biology Lab, Department of Experimental Medical Science, Faculty of Medicine, Lund Stem Cell Center, Lund University, Lund, Sweden.

ORCID-Profile: Zuzana Matusova, Werner Dykstra, Yolanda de Pablo, Oskar G Zetterdahl, Isaac Canals, Charlotte A G H van Gelder, Harmjan R Vos, Dolores Pérez-Sala, Mikael Kubista, Pavel Abaffy, Henrik Ahlenius, Lukas Valihrach, Elly M Hol, Milos Pekny

Förderung

  • EJP RD - European Joint Programme on Rare Diseases
  • Swedish Research Council
  • 'la Caixa' Foundation
  • Avtal om Läkarutbildning och Forskning (ALF) Gothenburg
  • Amlöv's Foundation
  • E. Jacobson's Donation Fund
  • Institutional support (Czech Republic)
  • Czech Science Foundation

Zitieren

APA

Matusova, Z., Dykstra, W., de Pablo, Y., Zetterdahl, O. G., Canals, I., van Gelder, C. A. G. H., Vos, H. R., Pérez-Sala, D., Kubista, M., Abaffy, P., Ahlenius, H., Valihrach, L., Hol, E. M., & Pekny, M. (2025). Aberrant neurodevelopment in human iPS cell‐derived models of Alexander disease. Glia. https://doi.org/10.1002/glia.24618

Vancouver

Matusova Z, Dykstra W, de Pablo Y, Zetterdahl OG, Canals I, van Gelder CAGH, et al. Aberrant neurodevelopment in human iPS cell‐derived models of Alexander disease. Glia. 2025. doi:10.1002/glia.24618

BibTeX
@article{Matusova2025,
  author = {Matusova, Zuzana and Dykstra, Werner and de Pablo, Yolanda and Zetterdahl, Oskar G and Canals, Isaac and van Gelder, Charlotte A G H and Vos, Harmjan R and Pérez-Sala, Dolores and Kubista, Mikael and Abaffy, Pavel and Ahlenius, Henrik and Valihrach, Lukas and Hol, Elly M and Pekny, Milos},
  title = {Aberrant neurodevelopment in human iPS cell‐derived models of Alexander disease},
  journal = {Glia},
  year = {2025},
  doi = {10.1002/glia.24618}
}
Kostenlos starten →